Archive for the 'Irritable Bowel Syndrome' Category
$6.75M Awarded To Case Western Reserve To Study IBD
Investigators at Case Western Reserve University School of Medicine received a $6.75 million Program Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to study the role of innate immunity in inflammatory bowel disease (IBD)…
Original post by Wife of a Diabetic
No commentsRisk Factors For Chronic Cerebrospinal Venous Insufficiency Are Similar To Risk Factors For Developing Multiple Sclerosis: UB Study
Summary: A vascular condition called chronic cerebrospinal venous insufficiency (CCSVI), which has attracted global attention as possibly being correlated with MS has, for the first time, been studied for the presence of risk factors in subjects who do not have a neurological disease…
Original post by Wife of a Diabetic
No commentsProbiotics For Gut Health: VSL#3 Has Designations For Specific GI Issues
As clinical studies continue to validate the use of probiotics to help promote general gastrointestinal health, a growing U.S. market1 for probiotics indicates that the U.S. healthcare community and consumers alike are recognizing the value of these beneficial microorganisms…
Original post by Wife of a Diabetic
No commentsTargeted Antibiotic Drug Safest Among Recommended Treatments For Irritable Bowel Disease
Among the most commonly used treatments for irritable bowel syndrome which affects as many as 20 percent of the United States population a targeted antibiotic was shown to be the safest in a new study by Cedars-Sinai researchers, based on an analysis of 26 large-scale clinical trials. The study, for presentation at the American College of Gastroenterology annual meeting in Washington, D.C…
Original post by Wife of a Diabetic
No commentsStress Associated With Grief, Natural Disasters, And Emotional Abuse Plays Ongoing Role In IBS
The psychological and emotional traumas experienced over a lifetime — such as the death of a loved one, divorce, natural disaster, house fire or car accident, physical or mental abuse — may contribute to adult irritable bowel syndrome (IBS), according to the results of a study unveiled at the American College of Gastroenterology’s (ACG) 76th Annual Scientific meeting in Washington, DC…
Original post by Wife of a Diabetic
No commentsResearch Could Lead To New Treatments For IBD, Viral Infections
The intestinal ecosystem is even more dynamic than previously thought, according to two studies by UT Southwestern Medical Center researchers published in the latest issue of Science…
Original post by Wife of a Diabetic
No commentsNegative Emotions Influence Brain Activity During Anticipation And Experience Of Pain
Neuroticism – the tendency to experience negative emotions – significantly affects brain processing during pain, as well as during the anticipation of pain, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association…
Original post by Wife of a Diabetic
No commentsNovel Cytokine Protects Mice From Colitis
Inflammatory bowel disease (IBD), which affects more than 1 million patients in North America, results from an uncontrolled immune response triggered by environmental factors, such as bacteria, in people genetically predisposed to the disorder. Ulcerative colitis, or inflammation of the lining of the colon, is one such condition…
Original post by Six Until Me.
No commentsWhere’s The Beef? Recalled! 60,000 Pounds Off Major Market Shelves
This pesky E. Coli bacteria is getting on the nation’s nerves, and in an effort to keep it off our plates, at least three major grocery market chains have recalled some of their ground beef packages because they could be contaminated with bacteria critter. The U.S…
Original post by Six Until Me.
No commentsLexicon Announces Publication Of Results From The Phase 2 Trial Of LX1031 In Patients With Irritable Bowel Syndrome In Journal Of Gastroenterology
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering breakthrough treatments for human disease, announced today that results from the Phase 2 clinical trial of LX1031 in patients with non-constipating irritable bowel syndrome (IBS) were published earlier this week in the August 2011 edition of the journal Gastroenterology…
Original post by Six Until Me.
No comments